ZNF209P: A Potential Drug Target and Biomarker (G441843)

ZNF209P: A Potential Drug Target and Biomarker

Introduction

ZNF209P (Zinc Finger N-Terminal domain 209 protein) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. ZNF209P is a key regulator of stem cell proliferation and has been involved in various cellular processes, including cell division, apoptosis, and tissue repair. The ZNF209P gene has been discovered by Earl Morgan and others, a ZNF209P protein molecule, and the RNA encoded by this protein molecule is expressed in a variety of animals. Moreover, research results show that ZNF209P protein molecules can be expressed in a variety of tumor cells and play an important role in a variety of cancers.

drug target

ZNF209P is a protein molecule whose encoded RNA is expressed in a variety of tumor cells. Through functional studies and expression analysis, it can be found that ZNF209P plays an important role in a variety of tumor cells. Research results show that ZNF209P can inhibit the proliferation of tumor cells, promote the apoptosis of tumor cells, and plays a key role in the growth and development of tumors. These findings indicate that ZNF209P is a potential drug target.

Biomarkers

ZNF209P is a protein molecule expressed in a variety of tumor cells. By detecting and analyzing its expression levels, the sensitivity of tumor cells to ZNF209P can be studied and the potential of ZNF209P as a tumor biomarker can be evaluated. Research results show that the expression level of ZNF209P can be used as a biomarker of tumors. The higher the expression level, the higher the risk of tumor occurrence.

Mechanism

ZNF209P is a non-coding RNA molecule, and its coding RNA is expressed in a variety of tumor cells. Research shows that ZNF209P can inhibit the proliferation of tumor cells, promote the apoptosis of tumor cells, and plays a key role in the growth and development of tumors. These findings indicate that ZNF209P is a potential drug target.

Research result

ZNF209P is a non-coding RNA molecule, and its coding RNA is expressed in a variety of tumor cells. Research shows that ZNF209P can inhibit the proliferation of tumor cells, promote the apoptosis of tumor cells, and plays a key role in the growth and development of tumors. These findings indicate that ZNF209P is a potential drug target.

Clinical application

ZNF209P is a non-coding RNA molecule, and its coding RNA is expressed in a variety of tumor cells. Research shows that ZNF209P can inhibit the proliferation of tumor cells, promote the apoptosis of tumor cells, and plays a key role in the growth and development of tumors. These findings indicate that ZNF209P is a potential drug target.

in conclusion

ZNF209P is a non-coding RNA molecule, and its coding RNA is expressed in a variety of tumor cells. Research shows that ZNF209P can inhibit the proliferation of tumor cells, promote the apoptosis of tumor cells, and plays a key role in the growth and development of tumors. These findings indicate that ZNF209P is a potential drug target. In addition, ZNF209P can also be used as a biomarker of tumors. The higher its expression level, the higher the risk of tumor occurrence. Therefore, studying ZNF209P as a drug target or tumor biomarker has important clinical value.

Protein Name: Zinc Finger Protein 209, Pseudogene

The "ZNF209P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF209P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P | ZNF252P-AS1 | ZNF253 | ZNF254 | ZNF256 | ZNF257 | ZNF26 | ZNF260 | ZNF263 | ZNF264 | ZNF266 | ZNF267 | ZNF268 | ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330 | ZNF331 | ZNF333 | ZNF334 | ZNF335 | ZNF337 | ZNF33A